SoumyaNC I only worry about genAI dumbing people down. As shown by the direction of this thread. (People would have been more receptive if your last post was the first post … I’ve done my job as an educator to get you to correct endpoint … hurrah).
Anyone with an NP3 and an understanding of Series A-D to IPO would understand potential lapses in legacy support when new products roll out. It’s predictable as you stated, so I find this entire thread confusing as it’s expected (what I am doing here is providing context for why that would happen). The dev budget at NTL has to be smaller than any other reasonably sized brand. One could argue that they have fewer phones to support (NP1/NP2/NP2a/NP3a/NP3apro/NP3/CMF1/CMF2pro) but that budget will go quickly. That biotech I was in burnt through USD 150MM in ~12 months with only 50 employees and no actual product costs.
The net positive of NTL is that they can more flexible in their hardware approach than an established firm. They can’t compete on price but they can compete on design/OS (NOTHING OS is indeed stellar) and when limited resources exist to deploy one can estimate where they’ll be deployed and it should be obvious that a smaller percentage will go to legacy devices than R&D for the next device.
(Providing the context is very important and this where genAI usually fails … as it has no experience to pull from and just make synopses of written text. It also should demonstrate to others how genAI output is received by the layperson/public).
